Archon Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.9M Buy
35,000
+4,000
+13% +$1.64M 1.54% 22
2026
Q2
$12.1M Buy
+31,000
New +$13.1M 1.29% 31
2020
Q1
– Sell
-72,000
Closed -$10.6M – 59
2019
Q4
$10.6M Hold
72,000
– – 1.81% 25
2019
Q3
$8.67M Hold
72,000
– – 1.68% 29
2019
Q2
$9.7M Hold
72,000
– – 1.93% 24
2019
Q1
$9.39M Buy
72,000
+400
+0.6% +$53.7K 1.98% 24
2018
Q4
$8.91M Hold
71,600
– – 2.22% 22
2018
Q3
$10M Buy
71,600
+1,100
+2% +$137K 2.03% 23
2018
Q2
$7.23M Buy
+70,500
New +$7.13M 1.57% 33

Other funds holding HCA

Archon Partners's HCA Position: Q3 2026 in Review

Archon Partners increased its HCA Healthcare (HCA) stake by 13% in Q3 2026, buying an estimated $1.64M and bringing the position to 35,000 shares worth $14.9M. The position accounts for 1.54% of the portfolio, ranked #22.

Archon Partners first reported a position in HCA in Q2 2018 and has held it in 9 quarters since. 848 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Archon Partners held 35,000 shares of HCA Healthcare worth $14.9M as of Q3 2026.
  • Archon Partners bought 4,000 HCA Healthcare shares in Q3 2026, an estimated $1.64M.
  • HCA Healthcare made up 1.54% of Archon Partners's portfolio in Q3 2026, its #22 holding.
  • Archon Partners first reported a position in HCA Healthcare in Q2 2018 and has held it in 9 quarters since.
  • 848 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Archon Partners's 13F filing for Q3 2026, filed 26 Oct 2026.